A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Recruiting

Phase 1

Phase 2

BMS-986470A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Sponsor:

Bristol-Myers Squibb

Code:

NCT06481306

Conditions

Anemia, Sickle Cell

Healthy Volunteers

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

BMS-986470

Placebo

Famotidine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-18. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2025-10-31.